CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency

Abstract Immunodeficient mice engrafted with either normal or cancerous human cells are widely used in basic and translational research. In particular, NOD/SCID/IL2rg−/− mice can support the growth of various types of human cancer cells. However, the hairs of these mice interfere with the observatio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xinru Wei, Yunxin Lai, Baiheng Li, Le Qin, Youdi Xu, Simiao Lin, Suna Wang, Qiting Wu, Qiubin Liang, Guohua Huang, Qiuhua Deng, Pentao Liu, Donghai Wu, Liangxue Lai, Yao Yao, Peng Li
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f445669279734610a20d18779a5652b2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f445669279734610a20d18779a5652b2
record_format dspace
spelling oai:doaj.org-article:f445669279734610a20d18779a5652b22021-12-02T11:40:58ZCRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency10.1038/s41598-017-08337-82045-2322https://doaj.org/article/f445669279734610a20d18779a5652b22017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-08337-8https://doaj.org/toc/2045-2322Abstract Immunodeficient mice engrafted with either normal or cancerous human cells are widely used in basic and translational research. In particular, NOD/SCID/IL2rg−/− mice can support the growth of various types of human cancer cells. However, the hairs of these mice interfere with the observation and imaging of engrafted tissues. Therefore, novel hairless strains exhibiting comparable immunodeficiency would be beneficial. Recently, the CRISPR/Cas9 system has been used for efficient multiplexed genome editing. In the present study, we generated a novel strain of nude NOD/SCID/IL2rg−/− (NSIN) mice by knocking out Foxn1 from NOD/SCID/IL2rg−/− (NSI) mice using the CRISPR/Cas9 system. The NSIN mice were deficient in B, T, and NK cells and not only showed impaired T cell reconstitution and thymus regeneration after allogeneic bone marrow nucleated cell transplantation but also exhibited improved capacity to graft both leukemic and solid tumor cells compared with NSI, NOG, and NDG mice. Moreover, the NSIN mice facilitated the monitoring and in vivo imaging of both leukemia and solid tumors. Therefore, our NSIN mice provide a new platform for xenograft mouse models in basic and translational research.Xinru WeiYunxin LaiBaiheng LiLe QinYoudi XuSimiao LinSuna WangQiting WuQiubin LiangGuohua HuangQiuhua DengPentao LiuDonghai WuLiangxue LaiYao YaoPeng LiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Xinru Wei
Yunxin Lai
Baiheng Li
Le Qin
Youdi Xu
Simiao Lin
Suna Wang
Qiting Wu
Qiubin Liang
Guohua Huang
Qiuhua Deng
Pentao Liu
Donghai Wu
Liangxue Lai
Yao Yao
Peng Li
CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency
description Abstract Immunodeficient mice engrafted with either normal or cancerous human cells are widely used in basic and translational research. In particular, NOD/SCID/IL2rg−/− mice can support the growth of various types of human cancer cells. However, the hairs of these mice interfere with the observation and imaging of engrafted tissues. Therefore, novel hairless strains exhibiting comparable immunodeficiency would be beneficial. Recently, the CRISPR/Cas9 system has been used for efficient multiplexed genome editing. In the present study, we generated a novel strain of nude NOD/SCID/IL2rg−/− (NSIN) mice by knocking out Foxn1 from NOD/SCID/IL2rg−/− (NSI) mice using the CRISPR/Cas9 system. The NSIN mice were deficient in B, T, and NK cells and not only showed impaired T cell reconstitution and thymus regeneration after allogeneic bone marrow nucleated cell transplantation but also exhibited improved capacity to graft both leukemic and solid tumor cells compared with NSI, NOG, and NDG mice. Moreover, the NSIN mice facilitated the monitoring and in vivo imaging of both leukemia and solid tumors. Therefore, our NSIN mice provide a new platform for xenograft mouse models in basic and translational research.
format article
author Xinru Wei
Yunxin Lai
Baiheng Li
Le Qin
Youdi Xu
Simiao Lin
Suna Wang
Qiting Wu
Qiubin Liang
Guohua Huang
Qiuhua Deng
Pentao Liu
Donghai Wu
Liangxue Lai
Yao Yao
Peng Li
author_facet Xinru Wei
Yunxin Lai
Baiheng Li
Le Qin
Youdi Xu
Simiao Lin
Suna Wang
Qiting Wu
Qiubin Liang
Guohua Huang
Qiuhua Deng
Pentao Liu
Donghai Wu
Liangxue Lai
Yao Yao
Peng Li
author_sort Xinru Wei
title CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency
title_short CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency
title_full CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency
title_fullStr CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency
title_full_unstemmed CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency
title_sort crispr/cas9-mediated deletion of foxn1 in nod/scid/il2rg−/− mice results in severe immunodeficiency
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/f445669279734610a20d18779a5652b2
work_keys_str_mv AT xinruwei crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT yunxinlai crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT baihengli crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT leqin crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT youdixu crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT simiaolin crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT sunawang crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT qitingwu crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT qiubinliang crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT guohuahuang crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT qiuhuadeng crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT pentaoliu crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT donghaiwu crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT liangxuelai crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT yaoyao crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
AT pengli crisprcas9mediateddeletionoffoxn1innodscidil2rgmiceresultsinsevereimmunodeficiency
_version_ 1718395496009039872